SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-022401
Filing Date
2020-05-07
Accepted
2020-05-07 08:30:22
Documents
3
Period of Report
2020-05-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K agle-8k_20200331.htm 8-K 37543
2 EX-99.1 agle-ex991_6.htm EX-99.1 201377
3 GRAPHIC g3bv4go2iicu000001.jpg GRAPHIC 3061
  Complete submission text file 0001564590-20-022401.txt   244438
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Filer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37722 | Film No.: 20854705
SIC: 2834 Pharmaceutical Preparations